US Patent 7981843 Antibody specificity transfer using minimal essential binding determinants
Patent 7981843 was granted and assigned to KaloBios Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7981843 Antibody specificity transfer using minimal essential binding determinants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.